Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MAIT cells in liver inflammation and fibrosis
Hema Mehta, Martin J. Lett, Paul Klenerman, et al.
Seminars in Immunopathology (2022) Vol. 44, Iss. 4, pp. 429-444
Open Access | Times Cited: 23

Showing 23 citing articles:

The microbiota and the gut–liver axis in primary sclerosing cholangitis
Johannes R. Hov, Tom H. Karlsen
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 3, pp. 135-154
Closed Access | Times Cited: 54
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Anna Alisi, Geoffrey W. McCaughan, Henning Grønbæk
Hepatology International (2024) Vol. 18, Iss. S2, pp. 861-872
Closed Access | Times Cited: 9
Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions
Mengyao Yan, Cui Yi-min, Qian Xiang
Theranostics (2025) Vol. 15, Iss. 5, pp. 1715-1740
Open Access | Times Cited: 1
Biological functions and therapeutic applications of human mucosal-associated invariant T cells
Ying Fang, Yuning Chen, Shaoqiang Niu, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung‐Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 326-344
Open Access | Times Cited: 6
Innate immunity and early liver inflammation
Jordi Yang Zhou
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Understanding Liver Transplantation Outcomes Through the Lens of Its Tissue-resident Immunobiome
Amy Prosser, Paul Klenerman, Michaela Lucas
Transplantation (2025)
Closed Access
Liver transplant-facilitated CD161+Vα7.2+ MAIT cell recovery demonstrates clinical benefits in hepatic failure patients
Wei Wang, Chen Dai, Peng Zhu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Tissue-resident and innate-like T cells in patients with advanced chronic liver disease
Oluwatomi Ibidapo-Obe, Tony Bruns
JHEP Reports (2023) Vol. 5, Iss. 10, pp. 100812-100812
Open Access | Times Cited: 7
Soluble CD46 as a diagnostic marker of hepatic steatosis
Florian Bitterer, Paul Kupke, Akinbami Adenugba, et al.
EBioMedicine (2024) Vol. 104, pp. 105184-105184
Open Access | Times Cited: 2
Emerging features of MAIT cells and other unconventional T cell populations in human viral disease and vaccination.
Carl-Philipp Hackstein, Paul Klenerman
Seminars in Immunology (2022) Vol. 61-64, pp. 101661-101661
Open Access | Times Cited: 11
MAIT cells in immune‐mediated tissue injury and repair
Alex Waterhölter, Malte Wunderlich, Jan‐Eric Turner
European Journal of Immunology (2023) Vol. 53, Iss. 12
Open Access | Times Cited: 6
Immunological scars after cure of hepatitis C virus infection: Long‐HepC?
Markus Cornberg, Jasmin Mischke, Anke Kraft, et al.
Current Opinion in Immunology (2023) Vol. 82, pp. 102324-102324
Open Access | Times Cited: 5
Phenotypic and functional characterization of pharmacologically expanded Vγ9Vδ2 T cells in pigtail macaques
Isaac M. Barber-Axthelm, Kathleen M. Wragg, Robyn Esterbauer, et al.
iScience (2023) Vol. 26, Iss. 3, pp. 106269-106269
Open Access | Times Cited: 4
Recent advances in the immunomodulation mechanism of mesenchymal stem cell therapy in liver diseases
Pingji Liu, Lichao Yao, Xue Hu, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 7, pp. 1099-1106
Open Access | Times Cited: 4
Hepatitis C virus chronicity and oncogenic potential: Vaccine development progress
Yuki Haga, Sydney Coates, Ranjit Ray
Molecular Aspects of Medicine (2024) Vol. 99, pp. 101305-101305
Closed Access | Times Cited: 1
Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis
Bonnie Bengtsson, Christopher Maucourant, Johan K. Sandberg, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0294695-e0294695
Open Access | Times Cited: 1
After the Storm: Persistent Molecular Alterations Following HCV Cure
Coline Seurre, Armando Andres Roca Suarez, Barbara Testoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7073-7073
Open Access | Times Cited: 1
Dysregulation and impaired anti-bacterial potential of mucosal-associated invariant T cells in autoimmune liver diseases
Wei Wang, Junmei Weng, Haoquan Zhang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113175-113175
Closed Access | Times Cited: 1
Reversion of liver cirrhosis after endovascular treatment in Chinese patients with Budd–Chiari syndrome
Chaoyang Wang, Tongqiang Li, Kequan Chen, et al.
Hepatology Research (2023) Vol. 53, Iss. 12, pp. 1198-1212
Closed Access | Times Cited: 2
Tolerance and autoimmunity in the liver
Christoph Schramm, Ye Htun Oo, Ansgar W. Lohse
Seminars in Immunopathology (2022) Vol. 44, Iss. 4, pp. 393-395
Open Access | Times Cited: 3
Liver transplant-facilitated recovery of MAIT cell from dysregulation in HBV-related liver failure demonstrates clinical benefits
Xiufang Weng, Wei Wang, Chen Dai, et al.
Research Square (Research Square) (2024)
Open Access
Blood MAIT cells phenotype in patients with Opisthorchis felineus invasion depending on the severity of liver fibrosis
В. В. Цуканов, N. E. Veselova, A. V. Vasyutin, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 15, pp. 139-145
Open Access
MAIT cells in chronic HBV infection‐related liver fibrosis: Friends or foes?
Fei Han, Yi‐Chao Zheng, Edwin Leeansyah
Clinical and Translational Discovery (2022) Vol. 2, Iss. 4
Open Access
Page 1

Scroll to top